-
Double Brilliance! Thinheal Pharma’s Peptide Manufacturing Base Receives EU Export Certificate for Tirzepatide API
Following the receipt of EU export certification for its Semaglutide API, Thinheal Pharma’s peptide manufacturing facility has once again received good news. The company’s GMP manufacturing base in Shaoxing, Zhejiang—Zhejiang Tasln Biopharma Co., Ltd.—has officially been issued an "Export Certificate for Active Pharmaceutical Ingredients (APIs) to the EU" (Certificate No.: ZJ260050) by the Zhejiang Provincial Medical Products Administration.
2026-03-23 admin 34
-
Thinheal Pharma — The Asia Pharma Expo 2026 in Bangladesh is about to commence; we cordially invite you to attend!
From March 29 to 31, 2026, the Asia Pharma Expo will be grandly held in Dhaka, the capital of Bangladesh. As one of the most influential events in the Asian pharmaceutical industry, this exhibition will bring together top-tier global pharmaceutical enterprises, R&D institutions, and industry experts to collectively explore the latest trends and future opportunities in pharmaceutical manufacturing. Hangzhou ThinHeal Pharma-Tech Co., Ltd. will make its debut in Bangladesh with its core team; we cordially invite both new and existing clients to visit our booth for discussions and business negotiations.
2026-03-23 admin 20
-
Good news! | Retatrutide API has officially received its FDA DMF number.
Recently, Hangzhou Thinheal Pharma -Tech Co., Ltd. successfully obtained Drug Master File (DMF) registration from the U.S. Food and Drug Administration (FDA) for its retatrutide active pharmaceutical ingredient (API) (DMF NUMBER ASSIGNED: 42912). This marks a new stage in the registration and application process for this product in the United States and represents another important milestone in the company's global expansion.
2026-01-28 admin 36
-
Notice Regarding the Use of ChemDraw Software
To all departments of the company: We recently received a communication from Hangzhou Zhengze Intellectual Property Service Co., Ltd. regarding the legalization of ChemDraw software. Currently, there are instances of pirated ChemDraw software being used in the market. Therefore, we hereby notify you of the following: In accordance with the relevant provisions of the "Regulations on the Protection of Computer Software of the People's Republic of China" and the "Copyright Law of the People's Republic of China," please conduct a self-inspection in all departments. If any personnel are using unauthorized ChemDraw software, they should immediately cease using it and uninstall the software. The company strictly prohibits the use of unauthorized software to prevent software quality issues during use.
2025-11-18 admin 58
微信
微信